Cancer Leadership Council
Based in MD
AI Overview
With $0 in lobbying spend across 32 quarterly filings, Cancer Leadership Council is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Cancer Leadership Council disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Medicare/Medicaid, Disaster Planning
HR 5247/S 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017
S. 204/P.L. 115-176, Right to Try Act of 2017
HR 6826, CLINICAL Treatment Act
Letter responding to Senator Lamar Alexander's request for ideas to reduce health care expenditures
Submit comments to Congress on proposals to strengthen Medicare Part D protections related to beneficiary cost-sharing
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.